Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...
Less than one in 1,000 US adolescents receive gender-affirming medication, researchers have revealed ahead of Trump's second ...
Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...
The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...
A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...
Fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications -- puberty blockers or ...
Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, ...
The findings, published in JAMA Pediatrics, suggest that fewer than 0.1% of all youth in the database received these medications. Only 926 adolescents were prescribed puberty blockers, and 1,927 ...